MAPT and Alzheimer disease: Here, we observed increased BBB leakage and pericyte degeneration in 2-month-old APOE4/4 mice (data not shown), and impaired behavior performance accompanied by AD typical pathologies (including abnormal deposition of Aβ and p-tau, neuron loss and microglial activation) in 18-month-old APOE4/4 mice.